182 related articles for article (PubMed ID: 33708434)
21. Aldolase A promotes epithelial-mesenchymal transition to increase malignant potentials of cervical adenocarcinoma.
Saito Y; Takasawa A; Takasawa K; Aoyama T; Akimoto T; Ota M; Magara K; Murata M; Hirohashi Y; Hasegawa T; Sawada N; Saito T; Osanai M
Cancer Sci; 2020 Aug; 111(8):3071-3081. PubMed ID: 32530543
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
[TBL] [Abstract][Full Text] [Related]
23. High expression of ALDOA and DDX5 are associated with poor prognosis in human colorectal cancer.
Dai L; Pan G; Liu X; Huang J; Jiang Z; Zhu X; Gan X; Xu Q; Tan N
Cancer Manag Res; 2018; 10():1799-1806. PubMed ID: 29988738
[TBL] [Abstract][Full Text] [Related]
24. Fructose-bisphosphate aldolase A is a key regulator of hypoxic adaptation in colorectal cancer cells and involved in treatment resistance and poor prognosis.
Kawai K; Uemura M; Munakata K; Takahashi H; Haraguchi N; Nishimura J; Hata T; Matsuda C; Ikenaga M; Murata K; Mizushima T; Yamamoto H; Doki Y; Mori M
Int J Oncol; 2017 Feb; 50(2):525-534. PubMed ID: 28000858
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of EWSR1 (Ewing sarcoma breakpoint region 1/EWS RNA binding protein 1) predicts poor survival in patients with hepatocellular carcinoma.
Jiang W; Wu T; Shi X; Xu J
Bioengineered; 2021 Dec; 12(1):7941-7949. PubMed ID: 34612781
[TBL] [Abstract][Full Text] [Related]
26. Hepatocellular carcinoma subtypes based on metabolic pathways reveals potential therapeutic targets.
He Z; Chen Q; He W; Cao J; Yao S; Huang Q; Zheng Y
Front Oncol; 2023; 13():1086604. PubMed ID: 36937389
[TBL] [Abstract][Full Text] [Related]
27. Development and validation of a robust epithelial-mesenchymal transition (EMT)-related prognostic signature for hepatocellular carcinoma.
Chen S; Zhao E
Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101587. PubMed ID: 33662631
[TBL] [Abstract][Full Text] [Related]
28. Increased E2F2 predicts poor prognosis in patients with HCC based on TCGA data.
Zeng Z; Cao Z; Tang Y
BMC Cancer; 2020 Oct; 20(1):1037. PubMed ID: 33115417
[TBL] [Abstract][Full Text] [Related]
29. In Silico Identification of Contradictory Role of ADAMTS5 in Hepatocellular Carcinoma.
Zhu Z; Xu J; Wu X; Lin S; Li L; Ye W; Huang Z
Technol Cancer Res Treat; 2021; 20():1533033820986826. PubMed ID: 33522433
[TBL] [Abstract][Full Text] [Related]
30. Integrated Analysis of FAM57A Expression and Its Potential Roles in Hepatocellular Carcinoma.
Wei J; Liu Y; Zhao C
Front Oncol; 2021; 11():719973. PubMed ID: 34790567
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of GINS4 Is Associated With Tumor Progression and Poor Survival in Hepatocellular Carcinoma.
Zhang Z; Chen P; Xie H; Cao P
Front Oncol; 2021; 11():654185. PubMed ID: 33842367
[TBL] [Abstract][Full Text] [Related]
32. High expression of fructose-bisphosphate aldolase A induces progression of renal cell carcinoma.
Huang Z; Hua Y; Tian Y; Qin C; Qian J; Bao M; Liu Y; Wang S; Cao Q; Ju X; Wang Z; Gu M
Oncol Rep; 2018 Jun; 39(6):2996-3006. PubMed ID: 29693182
[TBL] [Abstract][Full Text] [Related]
33. Clinical Significance and Potential Role of
Chen L; Lin YH; Liu GQ; Huang JE; Wei W; Yang ZH; Hu YM; Xie JH; Yu HZ
Front Genet; 2021; 12():804916. PubMed ID: 35096017
[No Abstract] [Full Text] [Related]
34. Overexpression of TONSL might be an independent unfavorable prognostic indicator in hepatocellular carcinoma.
Yu B; Ding Y; Liao X; Wang C; Wang B; Chen X
Pathol Res Pract; 2019 May; 215(5):939-945. PubMed ID: 30723051
[TBL] [Abstract][Full Text] [Related]
35. An epithelial-mesenchymal transition-related 5-gene signature predicting the prognosis of hepatocellular carcinoma patients.
Zhu G; Xia H; Tang Q; Bi F
Cancer Cell Int; 2021 Mar; 21(1):166. PubMed ID: 33712026
[TBL] [Abstract][Full Text] [Related]
36. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
[TBL] [Abstract][Full Text] [Related]
37. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.
Ma C; Kang W; Yu L; Yang Z; Ding T
Front Oncol; 2020; 10():590006. PubMed ID: 33363020
[TBL] [Abstract][Full Text] [Related]
38. The role of fructose 1,6-bisphosphate-mediated glycolysis/gluconeogenesis genes in cancer prognosis.
Li CH; Chan MH; Chang YC
Aging (Albany NY); 2022 Apr; 14(7):3233-3258. PubMed ID: 35404841
[TBL] [Abstract][Full Text] [Related]
39. Hydroxysteroid 17-Beta Dehydrogenase 6 Is a Prognostic Biomarker and Correlates with Immune Infiltrates in Hepatocellular Carcinoma.
Wu M; Jiang L
Dig Dis Sci; 2022 Jan; 67(1):146-158. PubMed ID: 33495920
[TBL] [Abstract][Full Text] [Related]
40. Five metastasis-related mRNAs signature predicting the survival of patients with liver hepatocellular carcinoma.
Chen C; Liu YQ; Qiu SX; Li Y; Yu NJ; Liu K; Zhong LM
BMC Cancer; 2021 Jun; 21(1):693. PubMed ID: 34116652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
